Evidence map›Paper›PMID 19013459›Full record

ArticleExperimental neurology2009

Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons.

Marina V Aksenova, Michael Y Aksenov, Sheila M Adams, Charles F Mactutus, Rosemarie M Booze

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Article
  4. HIV-1 Tat: Role in Bystander Toxicity.Frontiers in cellular and infection microbiology · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. HIV, Tat and dopamine transmission.Neurobiology of disease · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marina V AksenovaProgram in Behavioral Neuroscience, University of South Carolina, Columbia, SC 29208, USA.
Michael Y Aksenov
Sheila M Adams
Charles F Mactutus
Rosemarie M Booze
University of South Carolina · US

Funding

HIV/COCAINE NEUROTOXICITY IN FEMALESR01DA013137 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2000 to 2021
$7.7M
Maternal HIV: Developmental Neurotoxicity - Administrative SupplementR01HD043680 · NICHD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2003 to 2016
$2.8M
DEVELOPMENTAL NEUROTOXICITY OF COCAINE--AN IV RAT MODELR01DA009160 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI MACTUTUS, CHARLES F. · 1994 to 2001
$362k
Methamphetamine and HIV-1: NMDAR/D1 mediated neurologic effectsR03DA031604 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI MACTUTUS, CHARLES F. · 2011 to 2012
$290k
GENDER DIFFERENCES IN COCAINE RESPONSIVENESSR01DA011337 · NIDA · UNIVERSITY OF KENTUCKY · PI BOOZE, ROSEMARIE M · 1998 to 2000
$238k
NICHD NIH HHS HD 43680NICHD NIH HHS R01 HD043680NIDA NIH HHS DA 09160NIDA NIH HHS DA 11337NIDA NIH HHS DA 13137NIDA NIH HHS R01 DA009160NIDA NIH HHS R01 DA011337NIDA NIH HHS R01 DA013137NIDA NIH HHS R03 DA031604
6 · The paper itself

Abstract

In this study we report that primary cultures of rat fetal neurons contain subpopulations of cells that may be sensitive or resistant to HIV-1 Tat neurotoxicity. We demonstrate that rapid binding/uptake of Tat 1-86 for 2 h was sufficient to trigger caspase activation and neurodegeneration in rat fetal midbrain cell cultures. The uptake of Tat was followed by an increase in MCP1 (CCL2) immunoreactivity. Approximately 70% of neurons were able to survive transient or continuous (7 days) Tat exposure. The surviving neurons did not contain bound/internalized Tat, but were able to interact with Tat after medium replacement. These neurons were resistant to Tat toxicity. In neurons that resisted the toxic effects of continuous and repeated Tat treatment, levels of NR2A subunit of the NMDA receptor complex were significantly lower than in controls. We suggest that the subunit composition of NMDAR complexes may be important for the sensitivity of neurons to Tat toxicity.

Indexed as

AnimalsApoptosisCells, CulturedCell SurvivalChemokine CCL2Culture Media, ConditionedDose-Response Relationship, DrugEmbryo, MammalianEnzyme-Linked Immunosorbent AssayGene Products, tatMesencephalonNeuronsNeurotoxinsProtein BindingRatsRats, Sprague-DawleyCcl2 protein, ratChemokine CCL2Culture Media, ConditionedGene Products, tatNeurotoxinsReceptors, N-Methyl-D-Aspartatetat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID19013459
PMCPMC2663805
OpenAlexW1993184572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.